NCT06465641View on ClinicalTrials.gov

Methylphenidate in KBG Syndrome: N-of-1 Series

PHASE4RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

January 1, 2027

Study Completion Date

October 1, 2027

Conditions
Kbg SyndromeADHD - Combined Type
Interventions
DRUG

Methylphenidate Hydrochloride

Methylphenidate hydrochloride in capsules

DRUG

Placebo

Microcrystalline cellulose in capsules

Trial Locations (1)

6500 HB

RECRUITING

Radboud University Medical Center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT06465641 - Methylphenidate in KBG Syndrome: N-of-1 Series | Biotech Hunter | Biotech Hunter